Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Innovent Says PD-1 Meets Survival Endpoint in Phase III NSCLC Trial

Sirtex Doses First Patient in China Trial of Microsphere Radiation Therapy

Kintor Starts China Trial of Combination Therapy for Liver Cancer

Zai Lab Says HER2 Drug Meets Endpoints in Bridging Trial

Himalaya Files Four INDs in China for Conditionally Active Biologics

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China